« Return to News | CROs/Service Providers | Technology Solutions

Quintiles forms Digital Patient Unit

Tuesday, January 3, 2012 01:14 PM

Quintiles has formed a Digital Patient unit which brings together the company’s online communities and digital expertise to directly engage patients.

The goal of this new organization is to provide patients with information to better manage their personal health and to provide them with opportunities to participate in clinical research, observational studies and programs to better manage their conditions.

“Today, patients are as likely to seek information online about personal health as they are about the weather,” says David Coman, senior vice president at Quintiles and head of its new Digital Patient unit. “By unifying our digital patient resources, we will be better able to deliver proper content to patients while providing our customers with a more efficient channel to find the appropriate people who may be interested in participating in clinical, observational or disease management programs.”

Quintiles’ new Digital Patient unit has the ability to recruit patients by combing the digital universe for patients seeking information to manage their health, and its two patient communities, www.MediGuard.org and www.ClinicalResearch.com.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.